CVR Medical Corp V.CVM.H

Alternate Symbol(s): CRRVF

Healthcare Medical Devices

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.

TSXV:CVM.H - Post by User

CVR Medical Corp > Financials

<< Previous

Bullboard Posts

Next >>

Comment by OleMuleon Aug 12, 2020 4:37pm

171 Views

Post# 31400155

RE:Financials

Forgot to state off course the all unanimously agree with the exception of Trush, they are all either stakeholders and or large debt holders (services billed to CVR Med) in Global who wouldn't want more shares of Medical issued for IP that we do don't need. Medical already owns the rights globally for stroke why should we issue/dilute shares for applications that are years and years from commercialization and hundreds of millions of dollars worth of R&D when we have not even got the CSS for stroke across the finish line let alone cleared by FDA.

<< Previous

Bullboard Posts

Next >>

Catch up with companies that got a Stanley Cup Playoffs boost